Weight-Loss Drugs: A Survey on Americans’ Attitudes Toward New Injectables
Tuesday, 8 October 2024, 08:44
Consumer Sentiment on Weight-Loss Drugs
In a recent survey conducted by Morning Consult, it has been revealed that despite significant marketing campaigns for weight-loss drugs, particularly Wegovy and Ozempic, a majority of Americans remain skeptical about adopting these injectables.
Key Findings
- Many participants expressed concerns regarding the efficacy of the drugs.
- Side effects and long-term sustainability of weight loss were major factors influencing rejection.
- Public opinion suggests a preference for traditional weight management methods.
Overall, drug manufacturers may need to reassess their strategies to align with consumer beliefs and expectations regarding weight-loss solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.